BlackRock Investment Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $594K | Buy |
70,932
+204
| +0.3% | +$1.71K | ﹤0.01% | 2973 |
|
|
2016
Q3 | $486K | Buy |
70,728
+9,255
| +15% | +$63.6K | ﹤0.01% | 3041 |
|
|
2016
Q2 | $304K | Buy |
61,473
+7,660
| +14% | +$37.9K | ﹤0.01% | 3206 |
|
|
2016
Q1 | $520K | Buy |
53,813
+1,126
| +2% | +$10.9K | ﹤0.01% | 2879 |
|
|
2015
Q4 | $494K | Buy |
52,687
+428
| +0.8% | +$4.01K | ﹤0.01% | 3007 |
|
|
2015
Q3 | $735K | Buy |
52,259
+6,132
| +13% | +$86.2K | ﹤0.01% | 2824 |
|
|
2015
Q2 | $970K | Buy |
46,127
+28,945
| +168% | +$609K | ﹤0.01% | 2776 |
|
|
2015
Q1 | $721K | Buy |
17,182
+761
| +5% | +$31.9K | ﹤0.01% | 2746 |
|
|
2014
Q4 | $386K | Buy |
16,421
+907
| +6% | +$21.3K | ﹤0.01% | 3106 |
|
|
2014
Q3 | $232K | Buy |
+15,514
| New | +$232K | ﹤0.01% | 3213 |
|